These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 7104997

  • 1. High-dose 5-fluorouracil with delayed uridine "rescue" in mice.
    Martin DS, Stolfi RL, Sawyer RC, Spiegelman S, Young CW.
    Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997
    [Abstract] [Full Text] [Related]

  • 2. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON, Rais R, Shi J, Schinazi RF, Naguib FN, el Kouni MH.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [Abstract] [Full Text] [Related]

  • 3. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P, Cerna I.
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity.
    Schuetz JD, Wallace HJ, Diasio RB.
    Cancer Res; 1984 Apr; 44(4):1358-63. PubMed ID: 6704957
    [Abstract] [Full Text] [Related]

  • 7. Brequinar potentiates 5-fluorouracil antitumor activity in a murine model colon 38 tumor by tissue-specific modulation of uridine nucleotide pools.
    Pizzorno G, Wiegand RA, Lentz SK, Handschumacher RE.
    Cancer Res; 1992 Apr 01; 52(7):1660-5. PubMed ID: 1551097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW, von Borstel R.
    Cancer Chemother Pharmacol; 2006 Jul 01; 58(1):136-42. PubMed ID: 16187114
    [Abstract] [Full Text] [Related]

  • 17. Phase I and pharmacokinetic studies of high-dose uridine intended for rescue from 5-fluorouracil toxicity.
    Leyva A, van Groeningen CJ, Kraal I, Gall H, Peters GJ, Lankelma J, Pinedo HM.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5928-33. PubMed ID: 6498850
    [Abstract] [Full Text] [Related]

  • 18. Effect of a high-protein-low-carbohydrate diet on toxicity and antitumor activity of 5-fluorouracil in mice.
    Flanigen-Roat DT, Milholland RJ, Ip MM.
    J Natl Cancer Inst; 1985 Mar 01; 74(3):705-10. PubMed ID: 3856072
    [Abstract] [Full Text] [Related]

  • 19. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine +/- N-phosphonacetyl-L-aspartate in mice bearing advanced colon carcinoma 26.
    van Laar JA, Durrani FA, Rustum YM.
    Cancer Res; 1993 Apr 01; 53(7):1560-4. PubMed ID: 8453623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.